selenious acid has been researched along with Cancer of Ovary in 4 studies
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Song, M | 1 |
Kumaran, MN | 1 |
Gounder, M | 1 |
Gibbon, DG | 1 |
Nieves-Neira, W | 1 |
Vaidya, A | 1 |
Hellmann, M | 1 |
Kane, MP | 1 |
Buckley, B | 1 |
Shih, W | 1 |
Caffrey, PB | 2 |
Frenkel, GD | 2 |
Rodriguez-Rodriguez, L | 1 |
Liu, J | 1 |
Li, J | 1 |
Zhang, JF | 1 |
Xin, XY | 1 |
Ohkawa, K | 1 |
Tsukada, Y | 1 |
Dohzono, H | 1 |
Koike, K | 1 |
Terashima, Y | 1 |
1 trial available for selenious acid and Cancer of Ovary
Article | Year |
---|---|
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Lin | 2018 |
3 other studies available for selenious acid and Cancer of Ovary
Article | Year |
---|---|
Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Prolife | 2013 |
Selenite cytotoxicity in drug resistant and nonresistant human ovarian tumor cells.
Topics: Cell Adhesion; Cell Division; Cell Survival; Drug Resistance; Female; Humans; In Vitro Techniques; O | 1992 |
The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Respons | 1988 |